Biogen and Belgian partner UCB announce positive data from late-stage trial of lupus treatment
Biogen Inc.’s stock rose 2% early Tuesday, after the company and Belgian partner UCB announced positive results in a late-stage trial
Warren Buffett is a fan of energy stocks. Here’s one more strong buy signal.
Energy company insiders are purchasing far more shares than they’re selling. Here’s what they’re buying.
Snowflake stock drops on $2 billion debt plan
Snowflake outlined plans to raise $2 billion in debt to finance a $575 million share buyback plan and a series of possible acquisitions and strategic...
AutoZone’s stock drops after a rare profit miss, as U.S. sales come up short
AutoZone’s stock dropped in early Tuesday trading, after the auto-parts retailer reported quarterly earnings and sales that rose, but not enough to meet expectations, as...
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Legal & General hires PGIM exec to lead £1.1 trillion asset management business
Legal & General has named Eric Adler from US asset manager PGIM as its next chief executive, as the UK’s largest fund group looks to...
European luxury stocks surge on China’s new, far-reaching stimulus package
Europe’s luxury fashion firms are heavily reliant on Chinese consumers
‘I’m overwhelmed’: I inherited $185,000. With the Fed lowering rates, should I park it in 5% CDs or high-yield savings accounts?
“My brother got a better interest rate because he acted fast, and here I am twiddling my thumbs, overwhelmed with banks.”
If there’s a nuclear renaissance, here are the stocks to watch, says UBS
There’s genuine excitement in the air around nuclear power. Here are companies that can benefit.